Bionano Genomics
BNGO
30 hedge funds and large institutions have $291K invested in Bionano Genomics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 23 closing their positions.
3.72% more ownership
Funds ownership: 0.1% → 3.81% (+3.7%)
40% less funds holding
Funds holding: 50 → 30 (-20)
67% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 15
83% less capital invested
Capital invested by funds: $1.75M → $291K (-$1.46M)
87% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$122K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$54.8K |
| 3 |
Morgan Stanley
New York
|
+$20.3K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$19.8K |
| 5 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$903 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$118K |
| 2 |
Renaissance Technologies
New York
|
-$45.7K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$45.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$39.3K |
| 5 |
CAM
Carret Asset Management
New York
|
-$34.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$37 | -2 | Closed |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$13 | -2 | -13% |
|
|
CLOS
53
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$6 | – | – |
|
|
SS
54
Sunbelt Securities
Houston,
Texas
| – | -$4 | – | – |
|
BNGO Hedge Fund Activity: Q1 2025 in Review
30 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2025, worth a combined $291K — down 83% from $1.75M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BNGO and 3 opened new positions — a net loss of 20 holders — while 15 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $122K. The largest seller was Jane Street, exiting entirely with an estimated $118K sold.
- 30 institutional investors held Bionano Genomics (BNGO) as of Q1 2025, down from 50 in Q4 2024.
- Funds reported $291K of Bionano Genomics stock for Q1 2025, down 83% quarter-over-quarter.
- 3 funds opened new Bionano Genomics positions in Q1 2025 and 23 closed out, a net change of -20 holders.
- The largest Bionano Genomics buyer in Q1 2025 was Vanguard Group, an estimated $122K added.
- The largest Bionano Genomics seller in Q1 2025 was Jane Street, an estimated $118K sold.
Based on aggregated 13F filings for Q1 2025.